South Korea ensures compliance with Good Manufacturing Practice (GMP) standards for drug registration through inspections conducted by the Ministry of Food and Drug Safety (MFDS). Manufacturers must meet stringent requirements for facility management, production processes, and quality control. Regular audits, certifications, and... Read More
Good Manufacturing Practice (GMP) in South Korea ensures that drugs are consistently produced and controlled to meet quality standards. It covers all aspects of manufacturing, including raw materials, facilities, equipment, and staff. Compliance with GMP, enforced by the Ministry of Food and... Read More
Drug imports in South Korea are regulated by the Ministry of Food and Drug Safety (MFDS). Importers must obtain an Import Drug License, provide documentation on safety, quality, and efficacy, and comply with Good Import Practice (GIP) standards. MFDS inspects shipments, ensuring... Read More
South Korea regulates biosimilar registration through the Ministry of Food and Drug Safety (MFDS). Companies must submit data proving biosimilarity to the reference product in terms of safety, efficacy, and quality. This includes preclinical and clinical studies, along with manufacturing process details,... Read More
Vaccines in South Korea are registered through the Ministry of Food and Drug Safety (MFDS). The process involves submitting data on safety, efficacy, and quality from preclinical and clinical trials. Manufacturers must comply with Good Manufacturing Practice (GMP) standards, and vaccines undergo... Read More
South Korea regulates the manufacture of biologics through the Ministry of Food and Drug Safety (MFDS). Manufacturers must adhere to Good Manufacturing Practice (GMP) standards specific to biologics, ensuring product safety, efficacy, and quality. This involves stringent control of raw materials, production... Read More
In South Korea, bioequivalence requirements for generic drugs involve demonstrating that the generic product has similar bioavailability to the reference drug. This is achieved through clinical studies comparing the rate and extent of absorption. The Ministry of Food and Drug Safety (MFDS)... Read More
Generic drugs in South Korea are registered through the Ministry of Food and Drug Safety (MFDS). The process involves submitting data proving bioequivalence to the reference drug, along with manufacturing details that meet Good Manufacturing Practice (GMP) standards. Regulatory review ensures the... Read More
Phase I clinical trials in South Korea are conducted under strict guidelines set by the Ministry of Food and Drug Safety (MFDS). These trials focus on assessing safety, dosage, and pharmacokinetics in a small group of healthy volunteers. Compliance with Good Clinical... Read More
Submitting clinical data in South Korea requires adherence to guidelines set by the Ministry of Food and Drug Safety (MFDS). Data must demonstrate safety, efficacy, and quality, and be collected according to Good Clinical Practice (GCP) standards. Submissions include trial protocols, patient... Read More